Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Conference News VIVA 2019

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

L.A. McKeown

November 13, 2019

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Why RCTs Comparing EVAR With Open Repair for Ruptured AAAs are Misleading and Not Generally Applicable: EVAR is Best if it Can be Done

Presenter: Frank Veith

September 27, 2019

News Daily News

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

Caitlin E. Cox

August 09, 2019

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Daily News

Liberal IVC Filter Use Not Warranted in Severe Trauma Patients

Shelley Wood

July 08, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Daily News

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

Todd Neale

June 03, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

Advertisement

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Two Small Series Support Role for Cerebral Protection in TAVR

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Why RCTs Comparing EVAR With Open Repair for Ruptured AAAs are Misleading and Not Generally Applicable: EVAR is Best if it Can be Done

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Liberal IVC Filter Use Not Warranted in Severe Trauma Patients

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content